
Azenta, Inc. (0HQ1.L)
0HQ1.L Stock Price Chart
Explore Azenta, Inc. interactive price chart. Choose custom timeframes to analyze 0HQ1.L price movements and trends.
0HQ1.L Company Profile
Discover essential business fundamentals and corporate details for Azenta, Inc. (0HQ1.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
29 Jan 2018
Employees
3.00K
Website
https://www.azenta.comCEO
John P. Marotta
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
0HQ1.L Financial Timeline
Browse a chronological timeline of Azenta, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 10 Nov 2025
Upcoming earnings on 4 Aug 2025
Revenue estimate is $149.64M.
Earnings released on 7 May 2025
EPS came in at $0.05 falling short of the estimated $0.07 by -28.57%, while revenue for the quarter reached $143.42M, missing expectations by -4.16%.
Earnings released on 5 Feb 2025
EPS came in at -$0.29 falling short of the estimated $0.06 by -611.69%, while revenue for the quarter reached $147.51M, beating expectations by +3.96%.
Earnings released on 13 Nov 2024
EPS came in at $0.18 surpassing the estimated $0.10 by +75.61%, while revenue for the quarter reached $170.06M, beating expectations by +0.24%.
Earnings released on 7 Aug 2024
EPS came in at -$0.12 falling short of the estimated $0.08 by -252.62%, while revenue for the quarter reached $172.81M, beating expectations by +3.32%.
Earnings released on 9 May 2024
EPS came in at -$2.47 falling short of the estimated $0.02 by -10.52K%, while revenue for the quarter reached $159.13M, missing expectations by -0.14%.
Earnings released on 14 Mar 2024
EPS came in at -$0.28 falling short of the estimated -$0.03 by -715.53%, while revenue for the quarter reached $154.32M, beating expectations by +2.22%.
Earnings released on 14 Nov 2023
EPS came in at $0.06 surpassing the estimated $0.02 by +208.46%, while revenue for the quarter reached $172.36M, beating expectations by +5.14%.
Earnings released on 9 Aug 2023
EPS came in at -$0.04 falling short of the estimated -$0.03 by -49.35%, while revenue for the quarter reached $165.95M, beating expectations by +7.82%.
Earnings released on 10 May 2023
EPS came in at -$0.07 falling short of the estimated -$0.02 by -224.05%, while revenue for the quarter reached $148.40M, missing expectations by -8.34%.
Earnings released on 9 Feb 2023
EPS came in at -$0.15 falling short of the estimated $0.10 by -256.31%, while revenue for the quarter reached $178.37M, missing expectations by -1.66%.
Earnings released on 30 Sept 2022
EPS came in at -$0.30 falling short of the estimated $0.07 by -548.42%, while revenue for the quarter reached $137.57M, beating expectations by +2.88%.
Earnings released on 30 Jun 2022
EPS came in at -$0.11 falling short of the estimated $0.08 by -243.02%, while revenue for the quarter reached $132.74M, beating expectations by +0.03%.
Earnings released on 31 Mar 2022
EPS came in at -$5.89 falling short of the estimated $0.11 by -5.37K%, while revenue for the quarter reached $145.54M, beating expectations by +2.20%.
Earnings released on 31 Dec 2021
EPS came in at $0.58, while revenue for the quarter reached $139.65M.
Dividend declared on 2 Dec 2021
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 23 Dec 2021.
Earnings released on 30 Sept 2021
EPS came in at $0.29 surpassing the estimated $0.08 by +277.42%, while revenue for the quarter reached $136.94M, beating expectations by +1.06%.
Earnings released on 30 Jun 2021
EPS came in at $0.53, while revenue for the quarter reached $315.35M.
Earnings released on 31 Mar 2021
EPS came in at $0.32, while revenue for the quarter reached $286.59M.
Earnings released on 31 Dec 2020
EPS came in at $0.04, while revenue for the quarter reached $118.14M.
Earnings released on 30 Sept 2020
EPS came in at -$0.84, while revenue for the quarter reached -$262.54M.
0HQ1.L Stock Performance
Access detailed 0HQ1.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.